HIGHLIGHTS
- who: Nadjoua Maouche and colleagues from the Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom have published the Article: Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort, in the Journal: PLOS ONE of 22/08/2021
- what: In this real-world cohort the authors report outcomes with PanBorDex when used in later relapses and when administered in varying mitigated dosing schedules.
- how: Data were analyzed using IMB1 SPSS software package (version 26.0).
SUMMARY
Subgroup analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.